Emerging Cellular Therapies: T Cells and Beyond (B6): Joint with the meeting on Lymphocytes and their Roles in Cancer (R1)
Emerging Cellular Therapies: T Cells and Beyond (B6): Joint with the meeting on Lymphocytes and their Roles in Cancer (R1) is organized by Keystone Symposia on Molecular and Cellular Biology and will be held during Feb 11 - 15, 2018 at Keystone Resort, Keystone, Colorado, United States of America.
Course Summary :
A new community of researchers is emerging that focuses on studying and developing cellular therapies against cancer and chronic infections. The field is advancing rapidly due to our deepening understanding of cell biology. New technologies permit efficient cell culture, gene transfer and genetic editing, enabling autologous and allogeneic cell therapy. With the rapid development of CAR T cells, breakthrough FDA approval status, and fast-tracking clinical trials, competition is fierce in the biotechnology and pharmaceutical industries. Cell therapies with stem cells and T cells are in advanced clinical development that will enable widespread use of cancer and chronic infections such as HIV. Infusions of regulatory T cells (Tregs) have the potential to benefit patients with autoimmunity and transplantation. A goal of this conference is to bring together basic and translational scientists from these fields to identify current opportunities and challenges in cell therapies. Another goal is to bridge the fields of effector T cell and Treg cell therapies. The interdisciplinary features of this meeting should facilitate new collaborations and interactions between investigators who would not normally meet.
Additional Details will be posted as soon as they are available
|Contact No.||:||+1 800-253-0685|
|Registration Type||End Date||Price|
|Non student - Early fee||13 Dec,2017||USD 820.00|
|Non student - conference fee||10 Feb,2018||USD 1020.00|
|Student - Early fee||13 Dec,2017||USD 595.00|
|Student - Conference fee||10 Feb,2018||USD 795.00|